• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·603351.SS
Share

Nanjing Well Pharmaceutical Group Co.,Ltd. Stocks

CN¥ 26.28Last Updated 16.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 515.29M

CN¥ 26.28
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nanjing Well Pharmaceutical Group Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical excipients within the Chinese market. These essential auxiliary materials are utilized in both injectable and non-injectable drug formulations. Beyond its pharmaceutical focus, the company also supplies an extensive range of synthetic base oils for various industrial applications, including hydraulic fluids, lubricity additives for metals, metal quenching agents, compression lubricants, gear oils, chain lubricants, and base stocks for engine oils, heat transfer oils, and greases. Furthermore, its product portfolio diversifies into other specialized chemicals such as paints and coatings, textile chemicals, field chemicals, and low-foam metal cleaners. The company boasts a global presence, exporting its products to key markets in Europe, the United States, Southeast Asia, and other international regions. Originally known as Nanjing Well Pharmaceutical Co., Ltd., the company officially adopted its current name, Nanjing Well Pharmaceutical Group Co., Ltd., in April 2020.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.07.2026 02:57

The release of Google's cutting-edge AI model has been delayed by months — Bloomberg. Shares fell

17.07.2026 01:40

Alphabet and other tech stocks dragged down the entire market: the Nasdaq index fell 1.5%

17.07.2026 01:10

Trump Media will charge traders for quick access to Trump's posts

17.07.2026 00:31

Cathie Wood bought SpaceX shares during a dip ahead of a new Starship rocket test

16.07.2026 23:44

Chipmakers' stocks resumed their decline after a brief respite: What do TSMC and ASML have to do with this?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026